Vildagliptin 50.00 mg + Metformin Hydrochloride 850.00 mg

JALRA M 850mg is a fixed-dose combination medication that contains Vildagliptin (50.00mg/Tablet) and Metformin Hydrochloride (850.00mg/Tablet). Vildagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which help regulate blood sugar levels by increasing the release of insulin and reducing the production of glucose in the liver. Metformin Hydrochloride is a medication that works by decreasing the amount of glucose produced by the liver and improving the body's response to insulin. Together, these medications help control blood sugar levels in patients with type 2 diabetes mellitus. JALRA M 850mg is prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Take JALRA M 850mg orally with meals, as directed by your doctor. The dosage may vary based on your medical condition, response to treatment, and other medications you may be taking. Follow your doctor's instructions and do not exceed the recommended dosage.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.